SCHEMBL4533436

SCHEMBL4533436

Nc1csc(-c2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 5/20 0.48
CYP3A4 P08684 3/20 0.45
TSHR P16473 2/20 0.45
ABL1 P00519 1/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 3/20 0.43
KMO O15229 2/20 0.43
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
CYP1B1 Q16678 1/20 0.42
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PRKCZ Q05513 2/20 0.38
DHFR P00374 1/20 0.38
MAPK1 P28482 1/20 0.38
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10583935 0.80 IKBKB (0.46) ALDH1A1KDM4EMAPTL3MBTL1RAB9A
Hydrochloric Acid SCHEMBL10489602 0.78 IKBKB (0.45) ALDH1A1KDM4EMAPTL3MBTL1RAB9A
SCHEMBL23484323 0.77 AHR (0.48) AHRTSHRABL1ALDH1A1KDM4E
SCHEMBL25736152 0.77 AHR (0.48) AHRCYP3A4ABL1KDM4EMAPT
SCHEMBL17609932 0.74 KDM4E (0.53) AHRCYP3A4ABL1ALDH1A1KDM4E
SCHEMBL28016402 0.74 DYRK1B (0.35)
SCHEMBL19990277 0.72 HSD17B1 (0.55) CYP3A4ALDH1A1ALOX15HSD17B10KMT2A
SCHEMBL3082747 0.72 MAPT (0.44) CYP3A4ALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL28175721 0.72 IKBKB (0.46) CYP3A4ALDH1A1KDM4EMAPTRAB9A
SCHEMBL4489979 0.71 MAOA (0.48) CYP3A4TSHRALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 EP disclosed
US-20130303521-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC (US) 2013-11-14 US disclosed
US-20130165427-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC. (US) 2013-06-27 US disclosed
US-20130059869-A1 METHODS AND COMPOSITIONS FOR TREATING DISORDERS HYDRA BIOSCIENCES, INC. 2013-03-07 US disclosed
US-20120108614-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC. 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108614-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 AHR 1071/4885CYP3A4 2741/4885TSHR 4745/4885
US-20130303521-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 AHR 1071/4885CYP3A4 2741/4885TSHR 4745/4885
US-20130165427-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 AHR 1071/4885CYP3A4 2741/4885TSHR 4745/4885
US-20130059869-A1 METHODS AND COMPOSITIONS FOR TREATING DISORDERS TRPA1, TRPV1, TRPV3 AHR 535/4885CYP3A4 2805/4885TSHR 3225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.